HIOIX
Price
$10.91
Change
+$0.07 (+0.65%)
Updated
Apr 17 closing price
Net Assets
32.04M
JEPCX
Price
$13.32
Change
+$0.02 (+0.15%)
Updated
Apr 17 closing price
Net Assets
5.92B
Ad is loading...

HIOIX vs JEPCX

Header iconHIOIX vs JEPCX Comparison
Open Charts HIOIX vs JEPCXBanner chart's image
M3Sixty Income and Opportunity Instl
Price$10.91
Change+$0.07 (+0.65%)
VolumeN/A
Net Assets32.04M
JPMorgan Equity Premium Income C
Price$13.32
Change+$0.02 (+0.15%)
VolumeN/A
Net Assets5.92B
HIOIX vs JEPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HIOIX vs. JEPCX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIOIX is a Hold and JEPCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JEPCX has more cash in the bank: 5.92B vs. HIOIX (32M). JEPCX pays higher dividends than HIOIX: JEPCX (6.79) vs HIOIX (0.00). HIOIX was incepted earlier than JEPCX: HIOIX (9 years) vs JEPCX (7 years). HIOIX (2.76) is less costly to investors than JEPCX (1.35). HIOIX is a more actively managed with annual turnover of: 487.35 vs. JEPCX (176.00). JEPCX has a lower initial minimum investment than HIOIX: JEPCX (1000) vs HIOIX (2000). JEPCX annual gain was more profitable for investors over the last year : 3.04 vs. HIOIX (-2.50). JEPCX return over 5 years is better than : 58.24 vs. HIOIX (19.89).
HIOIXJEPCXHIOIX / JEPCX
Total Expense Ratio2.011.35149%
Annual Report Gross Expense Ratio2.761.35204%
Fund Existence9 years7 years-
Gain YTD-10.866-5.706190%
Front LoadN/AN/A-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets32M5.92B1%
Annual Yield % from dividends0.006.79-
Returns for 1 year-2.503.04-82%
Returns for 3 years13.4111.14120%
Returns for 5 years19.8958.2434%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLKGX69.770.32
+0.46%
Putnam Small Cap Growth R6
HGHSX37.25N/A
N/A
Hartford Healthcare R4
ISCSX14.29N/A
N/A
VY® Columbia Contrarian Core S
ABPRX76.97N/A
N/A
AB Large Cap Growth R
DRLYX7.97N/A
N/A
BNY Mellon Developed Markets RE Scs - Y